FDA/CDC

FDA safety alert: Face masks with metal can burn during MRI


 

After a patient’s face was burned in the outline of a mask worn during a 3-Tesla MRI neck scan, the US Food and Drug Administration (FDA) cautioned that face masks containing metal can heat to unsafe temperatures during scanning.

Clinicians have known for years to ask patients to remove all metal jewelry and other objects prior to an MRI. The widespread wearing of face masks during the COVID-19 pandemic, however, adds one more consideration to the list.

The FDA’s December 7 safety communication applies to surgical and nonsurgical face masks and respirators.

The injury risk relates to rapid heating of metal components. Many face masks contain a nose wire or metal clip that helps the product conform to the face. Some masks contain metal nanoparticles, while others feature antimicrobial coatings with silver or copper. Each of these products should be avoided during MRI scanning. Also watch out for staples on headbands, the FDA warned.

If the metal content of a face mask is unknown, the FDA suggests providing the patient with a facial covering that is known not to contain any metal.

Robert E. Watson Jr, MD, PhD, chair of the American College of Radiology (ACR) Committee on MR Safety, agreed. He recommended that facilities “provide patients with masks known to be MRI-safe and not permit patient-owned masks in the MRI.”

Watson suggested this strategy at a time when face masks are required.

“COVID-19 safety protocols require that patients wear masks when being scanned, to decrease infection risk to MRI staff, decrease risk of contaminating the MRI scanner, and to protect themselves from infection,” he told Medscape Medical News. “Any conducting metal that enters the MRI machine is at risk of heating due to the radiofrequency fields inherent to image generation.”

Adverse events related to the metal components of a face mask should be reported to the FDA using the MedWatch voluntary reporting form. In addition, healthcare providers subject to the FDA user facility reporting requirements should follow procedures at their facilities to report such events.

This article first appeared on Medscape.com.

Recommended Reading

ACIP: Health workers, long-term care residents first tier for COVID-19 vaccine
MDedge Hematology and Oncology
CDC shortens COVID-19 quarantine time to 10 or 7 days, with conditions
MDedge Hematology and Oncology
COVID-19 vaccine distribution could start in 2 weeks, Pence says
MDedge Hematology and Oncology
Diabetic retinopathy may predict greater risk of COVID-19 severity
MDedge Hematology and Oncology
Obesity, hypoxia predict severity in children with COVID-19
MDedge Hematology and Oncology
Infant’s COVID-19–related myocardial injury reversed
MDedge Hematology and Oncology
COVID-19–related outcomes poor for patients with hematologic disease in ASH registry
MDedge Hematology and Oncology
PPE shortage crisis continues at most hospitals, survey shows
MDedge Hematology and Oncology
COVID-19 and risk of clotting: ‘Be proactive about prevention’
MDedge Hematology and Oncology
Demand for COVID vaccines expected to get heated – and fast
MDedge Hematology and Oncology